Amber Dawn Ackerman, NP | |
2401 W University Ave, Muncie, IN 47303-3428 | |
(765) 747-3111 | |
Not Available |
Full Name | Amber Dawn Ackerman |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 2401 W University Ave, Muncie, Indiana |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013568724 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208600000X | Surgery | 71009345A (Indiana) | Secondary |
363LA2100X | Nurse Practitioner - Acute Care | 71009345A (Indiana) | Primary |
Mailing Address | Practice Location Address |
---|---|
Amber Dawn Ackerman, NP 250 N Shadeland Ave, Indianapolis, IN 46219-4959 Ph: () - | Amber Dawn Ackerman, NP 2401 W University Ave, Muncie, IN 47303-3428 Ph: (765) 747-3111 |
News Archive
Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, announced the commencement of a first-in-human study of CMX157, a novel lipid conjugate of the nucleotide tenofovir with in vitro activity against both tenofovir-sensitive and tenofovir-resistant human immunodeficiency virus (HIV). CMX157 has the potential to increase efficacy and decrease toxicity as compared to tenofovir, and may enable the creation of new 'one pill, once-a-day', fixed-dose combination regimens for the treatment of HIV infection.
As American Diabetes Month approaches, leading experts like Dr. Jacqueline Sutera, DPM, stress the importance of foot care, especially for those with diabetes. People with diabetes are at a greater risk of developing dry skin due to nerve damage.
Medical Diagnostic Laboratories, L.L.C. is a CLIA certified infectious disease laboratory which specializes in high-complexity, state-of-the-art, automated DNA-based molecular analyses.
Dementia may be an underlying cause of nearly three times more deaths in the U.S. than official records show, according to a new Boston University School of Public Health study.
A team from the University of Washington has unveiled a comprehensive portrait of the genome of the world's first immortal cell line, known as HeLa. The cell line was derived in 1951 from an aggressive cervical cancer that killed Henrietta Lacks, a 31-year-old African-American tobacco farmer and mother of five - the subject of the 2010 New York Times bestseller, The Immortal Life of Henrietta Lacks.
› Verified 5 days ago